StockData

Seaport Therapeutics, Inc. (SPTX) stock

SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.32+0.01 (+0.05%)

Close on Nov 19, 2026Market cap $980.68MP/E –Yield –

Seaport Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Seaport Therapeutics's shares outstanding was 54M at Sep 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 202654M+2171.3%
Q2 FY2026Jun 30, 202635M+1416.4%
Q1 FY2026Mar 31, 20262M–
Q3 FY2025Sep 30, 20252M–
Q2 FY2025Jun 30, 20252M–
Q1 FY2025Mar 31, 20252M–

More Seaport Therapeutics figures

See a number that looks wrong?